12:59 PM
 | 
Feb 15, 2019
 |  BC Extra  |  Politics & Policy

FDA releases final regenerative medicine guidances

FDA Friday released final versions of two guidance documents that are intended to facilitate the development of regenerative medicines.

Draft versions of the Evaluation of Devices Used with Regenerative Medicine Advanced Therapies and Expedited Programs for Regenerative Medicine Therapies for Serious Conditions were released in November 2017.

In the final guidance on expedited pathways, FDA confirmed that...

Read the full 282 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >